Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1994 1
1995 1
1998 4
2000 1
2003 6
2005 1
2006 1
2007 3
2008 3
2009 4
2010 7
2011 3
2012 9
2013 4
2014 14
2015 13
2016 15
2017 14
2018 16
2019 25
2020 28
2021 30
2022 33
2023 39
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %
The following terms were not found in PubMed: 20RJ, 5BAuthor
Page 1
Triceps brachii hypertrophy is substantially greater after elbow extension training performed in the overhead versus neutral arm position.
Maeo S, Wu Y, Huang M, Sakurai H, Kusagawa Y, Sugiyama T, Kanehisa H, Isaka T. Maeo S, et al. Eur J Sport Sci. 2023 Jul;23(7):1240-1250. doi: 10.1080/17461391.2022.2100279. Epub 2022 Aug 11. Eur J Sport Sci. 2023. PMID: 35819335 Free article.

Changes in muscle volume in Overhead-Arm compared to Neutral-Arm were 1.5-fold greater for the TB(Long) (+28.5% vs. +19.6%, Cohen's d = 0.61, P < 0.001), 1.4-fold greater for the TB(Lat+Med) (+14.6% vs. +10.5%, d = 0.39, P = 0.002), and 1.4-fold greater for the W

…
Changes in muscle volume in Overhead-Arm compared to Neutral-Arm were 1.5-fold greater for the TB(Long) (+28.5% vs. +19.6%, Cohen' …
Lecanemab Clarity AD: Quality-of-Life Results from a Randomized, Double-Blind Phase 3 Trial in Early Alzheimer's Disease.
Cohen S, van Dyck CH, Gee M, Doherty T, Kanekiyo M, Dhadda S, Li D, Hersch S, Irizarry M, Kramer LD. Cohen S, et al. J Prev Alzheimers Dis. 2023;10(4):771-777. doi: 10.14283/jpad.2023.123. J Prev Alzheimers Dis. 2023. PMID: 37874099 Clinical Trial.
MEASUREMENTS: HRQoL was measured at baseline and every 6 months using the European Quality of Life-5 Dimensions (EQ-5D-5L; by subject) and Quality of Life in AD (QOL-AD; by subject and proxy). ...RESULTS: A total of 1795 participants were enrolled (lecanemab:898; placebo:8 …
MEASUREMENTS: HRQoL was measured at baseline and every 6 months using the European Quality of Life-5 Dimensions (EQ-5D-5L; by subject …
Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction.
Pagnesi M, Metra M, Cohen-Solal A, Edwards C, Adamo M, Tomasoni D, Lam CSP, Chioncel O, Diaz R, Filippatos G, Ponikowski P, Sliwa K, Voors AA, Kimmoun A, Novosadova M, Takagi K, Barros M, Damasceno A, Saidu H, Gayat E, Pang PS, Celutkiene J, Cotter G, Mebazaa A, Davison B. Pagnesi M, et al. J Am Coll Cardiol. 2023 Jun 6;81(22):2131-2144. doi: 10.1016/j.jacc.2023.03.426. J Am Coll Cardiol. 2023. PMID: 37257948 Clinical Trial.
The treatment benefit of high-intensity care vs usual care on the primary endpoint was consistent across the whole LVEF spectrum (interaction P with LVEF as a continuous variable = 0.372). Mean difference in the EQ-5D visual analog scale change from baseline to day 90 betw …
The treatment benefit of high-intensity care vs usual care on the primary endpoint was consistent across the whole LVEF spectrum (interactio …
Exploratory clinical efficacy and patient-reported outcomes from NOVA: A randomized controlled study of intravenous natalizumab 6-week dosing versus continued 4-week dosing for relapsing-remitting multiple sclerosis.
Ryerson LZ, Foley JF, Defer G, Cohen JA, Arnold DL, Butzkueven H, Cutter G, Giovannoni G, Killestein J, Wiendl H, Sinks S, Kuhelj R, Bodhinathan K, Lasky T. Ryerson LZ, et al. Mult Scler Relat Disord. 2023 Apr;72:104561. doi: 10.1016/j.msard.2023.104561. Epub 2023 Feb 11. Mult Scler Relat Disord. 2023. PMID: 36931078 Free article. Clinical Trial.
Similarly, there were no significant differences between Q6W and Q4W groups in LSM change from baseline for any PRO (TSQM, -1.00, P = 0.410; Neuro-QoL fatigue, 0.52, P = 0.292; MSIS-29 Psychological, 0.67, P = 0.572; MSIS-29 Physical, 0.74, P = 0.429; EQ-5D-5 L, 0.00, P = …
Similarly, there were no significant differences between Q6W and Q4W groups in LSM change from baseline for any PRO (TSQM, -1.00, P = 0.410; …
Effectiveness and health benefits of a nutritional, chronobiological and physical exercise primary care intervention in fibromyalgia and chronic fatigue syndrome: SYNCHRONIZE + mixed-methods study protocol.
Carrasco-Querol N, González Serra G, Bueno Hernández N, Gonçalves AQ, Pastor Cazalla M, Bestratén Del Pino P, Montesó Curto P, Caballol Angelats R, Fusté Anguera I, Sancho Sol MC, Castro Blanco E, Vila-Martí A, Medina-Perucha L, Fernández-Sáez J, Dalmau Llorca MR, Aguilar Martín C. Carrasco-Querol N, et al. Medicine (Baltimore). 2023 Apr 25;102(17):e33637. doi: 10.1097/MD.0000000000033637. Medicine (Baltimore). 2023. PMID: 37115043 Free PMC article.
The intervention based on nutrition, chronobiology and physical exercise will be designed considering participants' opinions as collected in 4 focus groups. To evaluate effectiveness, EuroQol-5D, multidimensional fatigue inventory, VAS pain, Pittsburgh Sleep Quality Index, …
The intervention based on nutrition, chronobiology and physical exercise will be designed considering participants' opinions as collected in …
Symptoms of anxiety and depression in patients with persistent asthma: a cross-sectional analysis of the INSPIRERS studies.
Simões Cunha M, Amaral R, Pereira AM, Almeida R, Alves-Correia M, Loureiro CC, Lopes C, Carvalho J, Ribeiro C, Vidal C, Antolín-Amérigo D, Pinto D, Ferreira-Magalhães M, Vasconcelos MJ, Lozoya C, Santos N, Cardia F, Taborda-Barata L, Ferreira R, Morais Silva P, Ferreira TM, Câmara R, Silva E, Bordalo D, Guimarães C, Calix MJ, da Silva S, Marques ML, Morete A, Nunes C, Vieira C, Páscoa R, Alves A, Marques JV, Reis B, Monteiro L, Monteiro R, Cepa M, Valentim B, Coelho DS, Fernandes S, Meireles P, Aguiar MA, Mourão AR, Fonseca JA, Jácome C. Simões Cunha M, et al. BMJ Open. 2023 May 5;13(5):e068725. doi: 10.1136/bmjopen-2022-068725. BMJ Open. 2023. PMID: 37147092 Free PMC article.
A total of 614 adolescents and adults with persistent asthma (32.616.9 years, 64.7% female) were recruited from 30 primary care centres and 32 allergy, pulmonology and paediatric clinics. Demographic and clinical characteristics, HADS and EQ-5D were collected. A score 8 on …
A total of 614 adolescents and adults with persistent asthma (32.616.9 years, 64.7% female) were recruited from 30 primary care centres and …
Predicting Outcomes of Language Rehabilitation: Prognostic Factors for Immediate and Long-Term Outcomes After Aphasia Therapy.
Kristinsson S, Basilakos A, den Ouden DB, Cassarly C, Spell LA, Bonilha L, Rorden C, Hillis AE, Hickok G, Johnson L, Busby N, Walker GM, McLain A, Fridriksson J. Kristinsson S, et al. J Speech Lang Hear Res. 2023 Mar 7;66(3):1068-1084. doi: 10.1044/2022_JSLHR-22-00347. Epub 2023 Feb 24. J Speech Lang Hear Res. 2023. PMID: 36827514 Free PMC article. Clinical Trial.
Change in naming performance over time was evaluated using paired t tests, and linear mixed-effects models were constructed to examine the association between prognostic factors and therapy outcomes. RESULTS: Naming performance was improved by 5.9 PNT items (Cohen's …
Change in naming performance over time was evaluated using paired t tests, and linear mixed-effects models were constructed to examine the a …
Responsiveness to change in health status of the EQ-5D in patients treated for depression and anxiety.
Sandin K, Shields G, Gjengedal RGH, Osnes K, Bjørndal MT, Reme SE, Hjemdal O. Sandin K, et al. Health Qual Life Outcomes. 2023 Apr 15;21(1):35. doi: 10.1186/s12955-023-02116-y. Health Qual Life Outcomes. 2023. PMID: 37061712 Free PMC article.
Effect sizes (Cohen's d), Standardised response mean (SRM), and Pearson's correlation were calculated. ...Pearson's correlation showed strong agreement between change scores of the EQ-5D value and the BDI-II (r(s) -0.54) and moderate between the EQ-5D …
Effect sizes (Cohen's d), Standardised response mean (SRM), and Pearson's correlation were calculated. ...Pearson's correlatio …
Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome.
Cramer JA, Sapin C, François C. Cramer JA, et al. Acta Neurol Scand. 2013 Aug;128(2):91-9. doi: 10.1111/ane.12086. Epub 2013 Feb 15. Acta Neurol Scand. 2013. PMID: 23410109 Review.

As outcomes were not uniformly reported across studies, the primary efficacy endpoint from each trial was transformed into Cohen's d effect size, to facilitate indirect comparisons. Typical interpretations of Cohen's d results are as follows: d < 0.

…
As outcomes were not uniformly reported across studies, the primary efficacy endpoint from each trial was transformed into Cohen's …
Post-COVID-19 Ongoing Symptoms and Health-Related Quality of Life: Does Rehabilitation Matter?: Preliminary Evidence.
Mammi P, Ranza E, Rampello A, Ravanetti D, Cavaldonati A, Moretti S, Gobbi E, Rodà F, Brianti R. Mammi P, et al. Am J Phys Med Rehabil. 2023 Mar 1;102(3):241-244. doi: 10.1097/PHM.0000000000002089. Epub 2022 Aug 16. Am J Phys Med Rehabil. 2023. PMID: 36002109 Free PMC article.
Mean differences are as follows: breathlessness, -2.91; fatigue, -2.05; and pain, -2.41 ( P > 0.001). Quality of life measured with Euroqol-5D improved. Mean differences are as follows: Euroqol-5D index, 0.104, and Euroqol-5D visual analog scale, 19.21 ( P …
Mean differences are as follows: breathlessness, -2.91; fatigue, -2.05; and pain, -2.41 ( P > 0.001). Quality of life measured with Euroq …
252 results